IPC
HAE icon

Independent Portfolio Consultants’s Haemonetics HAE Stock Holding History

Independent Portfolio Consultants’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-195
Closed -$8K – 819
2015
Q2 		$8K Sell
195
-210
-52% -$8.85K ﹤0.01% 784
2015
Q1 		$18K Buy
405
+195
+93% +$8.15K ﹤0.01% 688
2014
Q4 		$8K Buy
210
+40
+24% +$1.47K ﹤0.01% 730
2014
Q3 		$6K Buy
+170
New +$6.07K ﹤0.01% 784

Other funds holding HAE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Independent Portfolio Consultants's HAE Position: Q3 2015 in Review

Independent Portfolio Consultants sold out of Haemonetics (HAE) in Q3 2015, closing a stake of 195 shares — an estimated $8K sold.

Independent Portfolio Consultants first reported a position in HAE in Q3 2014 and held it in 4 quarters. The position peaked at $18K in Q1 2015. 171 funds tracked by Wall St. Rank hold HAE as of Q3 2015.

  • Independent Portfolio Consultants reported no remaining Haemonetics position as of Q3 2015 after selling out during the quarter.
  • Independent Portfolio Consultants sold 195 Haemonetics shares in Q3 2015, an estimated $8K.
  • Independent Portfolio Consultants first reported a position in Haemonetics in Q3 2014 and held it in 4 quarters.
  • Independent Portfolio Consultants's Haemonetics position peaked at $18K in Q1 2015.
  • 171 funds tracked by Wall St. Rank held Haemonetics as of Q3 2015.

Based on Independent Portfolio Consultants's 13F filing for Q3 2015, filed 19 Oct 2015.